KATHMANDU, Dec 29: Nepali medical oncologist Dr Bishal Gyawali has been recognised as the world’s top expert in Global Oncology in the latest rankings by ScholarGPS, an international academic analytics platform that uses artificial intelligence to assess researchers’ productivity, citation impact and overall scholarly influence. In the 2025 ScholarGPS list, Dr Gyawali was ranked first worldwide in Global Oncology and seventh in Progression-Free Survival.
Dr Gyawali is an Associate Professor of Medical Oncology and Public Health Sciences and a scientist in the Division of Cancer Care and Epidemiology at Queen’s University in Kingston, Canada. His research focuses on global oncology, cancer policy, evidence-based clinical practice, cancer care disparities, financial toxicity of cancer treatments, and improving access to care in low- and middle-income countries (LMICs).
Dr Bishal Gyawali awarded Global Oncology Young Investigator Aw...
He has authored or co-authored more than 200 peer-reviewed articles in leading medical and oncology journals including JAMA Oncology, The Lancet Oncology, New England Journal of Medicine, Journal of Clinical Oncology and Nature Medicine. His work includes advocating for equitable, patient-centred cancer care and more effective clinical research methods worldwide.
Dr Gyawali also holds leadership roles on several global health and oncology advisory bodies. He serves on the Expert Advisory Panel on Drug Evaluation and the Essential Medicines List Working Group for Cancer Drugs of the World Health Organization, is a member of the Health Equity and Outcomes Committee of the American Society of Clinical Oncology (ASCO) and participates in multiple committees of the European Society for Medical Oncology (ESMO).
In 2020, Dr Gyawali received the Global Oncology Young Investigator Award from the Conquer Cancer Foundation of ASCO, becoming one of the first Nepali doctors to receive this honour. He has also received recognition from the Government of Nepal as a Young Health Researcher.
Originally from Nepal, Dr Gyawali completed his MBBS at Tribhuvan University and went on to earn a PhD in Medical Oncology at Nagoya University in Japan. He later trained and worked at leading institutions in North America before joining Queen’s University, where he continues to combine clinical practice, research and teaching.
Dr Gyawali’s global recognition is widely seen as a significant achievement for Nepal’s medical community and a testament to the impact Nepali professionals are making on the world stage.
